
|Slideshows|July 10, 2015
Drug Therapy in Epilepsy
Author(s)Mark L. Fuerst
Drug therapy is the mainstay of seizure treatment. We present recent findings in anti-epileptic drug research.
Advertisement
Drug therapy is the mainstay of seizure treatment. A combination of two anti-epileptic drugs, ezogabine and retigabine, has proven to be an effective adjunctive therapy in adults in partial-onset seizure. Another drug, Fycompa, has received an expanded indication as an adjunctive treatment of primary generalized tonic-clonic seizures in patients 12 years of age and older with epilepsy. However, the anti-epileptic eslicarbazepine leads to a high frequency of hyponatremia and its use needs to be monitored, especially in elderly post-stroke patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
2
What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease
3
Mapping the Clinical Trial Landscape for Stem Cell Therapies in Parkinson Disease
4
Stem Cell Therapy Versus Traditional Parkinson Treatments
5













